Attached files

file filename
EX-32.2 - EX-32.2 - HILLMAN COMPANIES INCexhibit322-certificati.htm
EX-32.1 - EX-32.1 - HILLMAN COMPANIES INCexhibit321-certificati.htm
EX-31.2 - EX-31.2 - HILLMAN COMPANIES INCexhibit312-certificati.htm
EX-31.1 - EX-31.1 - HILLMAN COMPANIES INCexhibit311-certificati.htm
10-Q - 10-Q - HILLMAN COMPANIES INChlm-20200926.htm
Exhibit 99
THE HILLMAN COMPANIES, INC. AND SUBSIDIARIES
RECONCILIATION OF ADJUSTED EBITDA (Unaudited)
(dollars in thousands)

EBITDA and Adjusted EBITDA are not measures made in accordance with U.S. generally accepted accounting principles (“GAAP”), and as such, should not be considered a measure of financial performance or condition, liquidity, or profitability. It should not be considered an alternative to GAAP-based net income or income from operations or operating cash flows. Further, because not all companies use identical calculations, amounts reflected by Hillman as EBITDA and Adjusted EBITDA may not be comparable to similarly titled measures of other companies. Adjusted EBITDA is included to satisfy a reporting obligation under our indenture. Adjusted EBITDA as presented herein does not include certain adjustments and pro forma run rate measures contemplated by our senior secured credit facilities and our indenture and may also include additional adjustments that were not applicable at the time of the offering of the senior notes governed by our indenture. Adjusted EBITDA is also one of the performance criteria for the Company's annual performance-based bonus plan. The reconciliation of Net loss to Adjusted EBITDA is presented below.

Thirteen Weeks Ended Thirty-nine Weeks Ended
September 26,September 28,September 26,September 28,
2020201920202019
Net income (loss)$10,662 $(14,526)$(3,318)$(69,290)
Income tax provision (benefit)1,400 (3,775)(9,593)(1,844)
Interest expense, net20,688 24,882 67,746 77,509 
Interest expense on junior subordinated debentures3,219 3,152 9,555 9,456 
Investment income on trust common securities(94)(95)(283)(284)
Depreciation15,926 16,269 50,673 48,740 
Amortization14,883 14,665 44,596 44,114 
EBITDA66,684 40,572 159,376 108,401 
   Stock compensation expense1,148 1,243 3,818 1,906 
   Management fees130 140 451 396 
   Acquisition and integration expense1,054 2,757 2,044 5,225 
Retention and long term incentive bonuses— 2,030 — 6,089 
   Non-recurring legal fees2,979 — 5,654 — 
   Canada Restructuring (1)
651 1,874 3,362 3,111 
   U.S. Restructuring (2)
2,187 — 3,067 — 
   Restructuring and other costs (3)
1,254 2,905 2,693 13,027 
   Asset impairment costs(4)
— 96 210 6,896 
   Other non-recurring charges (5)
431 — 1,288 — 
Change in fair value of contingent consideration— — (1,300)— 
   Mark-to-market adjustment on interest rate swaps (773)315 1,169 3,217 
Adjusted EBITDA$75,745 $51,932 $181,832 $148,268 

1.Includes charges related to a restructuring plan announced in our Canada segment in 2018, including facility consolidation and charges relating to exiting certain lines of business. See Note 9 - Restructuring of the Notes to the Condensed Consolidated Financial statements for additional information.
2.Includes charges related to a restructuring plan announced in our United States business in the fourth quarter of 2019, including severance related to management realignment and the integration of sales and operating functions. See Note 9 - Restructuring of the Notes to the Condensed Consolidated Financial statements for additional information.
3.Includes one time charges associated with new business wins along with consulting and other costs associated with streamlining our manufacturing and distribution operations.
4.Impairment losses for the disposal of FastKey self-service key duplicating kiosks and related assets.
5.Includes ongoing expenses associated with manufacturing lines that were temporarily idle due to the pandemic.